Annual CFO
-$3.15 M
-$1.32 M-72.03%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual cash flow from operations is currently -$3.15 million, with the most recent change of -$1.32 million (-72.03%) on 01 December 2023. During the last 3 years, it has fallen by -$3.12 million (-10914.69%). LIPO annual CFO is now -10914.69% below its all-time high of -$28.60 thousand, reached on 01 December 2020.LIPO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$653.10 K
+$265.70 K+28.92%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly cash flow from operations is currently -$653.10 thousand, with the most recent change of +$265.70 thousand (+28.92%) on 01 September 2024. Over the past year, it has increased by +$74.60 thousand (+10.25%). LIPO quarterly CFO is now -676.58% below its all-time high of -$84.10 thousand, reached on 01 March 2021.LIPO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$3.69 M
+$36.30 K+0.97%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM cash flow from operations is currently -$3.69 million, with the most recent change of +$36.30 thousand (+0.97%) on 01 September 2024. Over the past year, it has dropped by -$537.80 thousand (-17.07%). LIPO TTM CFO is now -4285.26% below its all-time high of -$84.10 thousand, reached on 01 March 2021.LIPO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +10.3% | -17.1% |
| 3 y3 years | -10000.0% | -38.6% | -272.8% |
| 5 y5 years | - | - | - |
LIPO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -182.0% | +53.0% | -272.8% | +1.0% |
| 5 y | 5 years | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.0% |
| alltime | all time | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.0% |
Lipella Pharmaceuticals Common Stock Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$653.10 K(-28.9%) | -$3.69 M(-1.0%) |
| June 2024 | - | -$918.80 K(-33.8%) | -$3.72 M(+7.6%) |
| Mar 2024 | - | -$1.39 M(+90.8%) | -$3.46 M(+9.9%) |
| Dec 2023 | -$3.15 M(+72.0%) | -$727.70 K(+5.6%) | -$3.15 M(+18.7%) |
| Sept 2023 | - | -$689.40 K(+5.2%) | -$2.65 M(+16.2%) |
| June 2023 | - | -$655.10 K(-39.2%) | -$2.28 M(+3.4%) |
| Mar 2023 | - | -$1.08 M(+365.5%) | -$2.21 M(+20.7%) |
| Dec 2022 | -$1.83 M | -$231.60 K(-27.7%) | -$1.83 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$320.20 K(-44.8%) | -$2.07 M(+8.9%) |
| June 2022 | - | -$580.00 K(-17.1%) | -$1.90 M(+18.5%) |
| Mar 2022 | - | -$699.40 K(+48.4%) | -$1.60 M(+62.2%) |
| Dec 2021 | -$989.30 K(+3359.1%) | - | - |
| Dec 2021 | - | -$471.20 K(+212.3%) | -$989.30 K(+90.9%) |
| Sept 2021 | - | -$150.90 K(-46.7%) | -$518.10 K(+41.1%) |
| June 2021 | - | -$283.10 K(+236.6%) | -$367.20 K(+336.6%) |
| Mar 2021 | - | -$84.10 K | -$84.10 K |
| Dec 2020 | -$28.60 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual cash flow from operations?
- What is the all time high annual CFO for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly CFO year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM cash flow from operations?
- What is the all time high TTM CFO for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM CFO year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual cash flow from operations?
The current annual CFO of LIPO is -$3.15 M
What is the all time high annual CFO for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual cash flow from operations is -$28.60 K
What is Lipella Pharmaceuticals Common Stock quarterly cash flow from operations?
The current quarterly CFO of LIPO is -$653.10 K
What is the all time high quarterly CFO for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly cash flow from operations is -$84.10 K
What is Lipella Pharmaceuticals Common Stock quarterly CFO year-on-year change?
Over the past year, LIPO quarterly cash flow from operations has changed by +$74.60 K (+10.25%)
What is Lipella Pharmaceuticals Common Stock TTM cash flow from operations?
The current TTM CFO of LIPO is -$3.69 M
What is the all time high TTM CFO for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM cash flow from operations is -$84.10 K
What is Lipella Pharmaceuticals Common Stock TTM CFO year-on-year change?
Over the past year, LIPO TTM cash flow from operations has changed by -$537.80 K (-17.07%)